Metropolis Healthcare Ltd.
| BSE: 542650 | Sector: Health care |
| NSE: METROPOLIS | ISIN Code: INE112L01020 |
| BSE 00:00 | 27 Jan | 1299.70 |
1.50 (0.12%) |
OPEN
1303.05 |
HIGH
1321.95 |
LOW
1282.05 |
| NSE 00:00 | 27 Jan | 1300.90 |
2.30 (0.18%) |
OPEN
1299.10 |
HIGH
1322.40 |
LOW
1282.45 |
| OPEN | 1303.05 |
| PREVIOUS CLOSE | 1298.20 |
| VOLUME | 4935 |
| 52-Week high | 2670.00 |
| 52-Week low | 1268.45 |
| P/E | 48.79 |
| Mkt Cap.(Rs cr) | 6,654 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Metropolis Healthcare Ltd. (METROPOLIS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 1043.60 | 3.65 | 0.35 | 15585.98 |
| Dr Reddy's Labs | 4318.30 | 113.75 | 2.71 | 14405.20 |
| Cipla | 1047.05 | 12.65 | 1.22 | 13091.79 |
| Lupin | 742.20 | -4.10 | -0.55 | 11771.67 |
| Aurobindo Pharma | 416.25 | -1.60 | -0.38 | 11287.14 |
| Divi's Lab. | 3385.55 | 49.05 | 1.47 | 8879.82 |
| Alkem Lab | 2997.60 | -16.20 | -0.54 | 8829.81 |
| Glenmark Pharma. | 381.40 | -17.60 | -4.41 | 8141.58 |
| Zydus Lifesci. | 430.25 | 4.15 | 0.97 | 7981.90 |
| Torrent Pharma. | 1537.80 | -19.70 | -1.26 | 6742.32 |
| Apollo Hospitals | 4243.30 | 18.20 | 0.43 | 6098.30 |
| Ipca Labs. | 850.60 | -13.40 | -1.55 | 5399.36 |
| Alembic Pharma | 538.10 | -7.85 | -1.44 | 5035.41 |
| Abbott India | 21219.85 | -60.15 | -0.28 | 4919.27 |
| Laurus Labs | 341.85 | -0.15 | -0.04 | 4707.04 |
| Gland Pharma | 1357.10 | 15.55 | 1.16 | 4400.71 |
| Granules India | 284.10 | -4.65 | -1.61 | 3238.44 |
| Glaxosmi. Pharma | 1261.60 | -1.35 | -0.11 | 3217.51 |
| Ajanta Pharma | 1181.85 | -11.55 | -0.97 | 3140.64 |
| Piramal Pharma | 102.90 | -5.35 | -4.94 | 3094.95 |
Quick Links for Metropolis Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
